Gel Increases Success Rate of AVF Development
Researchers at the University of Alabama at Birmingham and Endomimetics, a biotechnology company, have showed that a self-assembling, nanomatrix gel that releases nitric oxide helped create a fully developed arteriovenous fistula (AVF) in rodents. The gel helps prevent overgrowth of cells at the anastomosis.
Read the full article » | Posted 01-14-2022
Related Articles
- The Lancet Digital Health published results of Humacyte’s Phase III clinical trial of its V007 acellular tissue engineered vessel (ATEV) HD access Posted 09-18-2026
- Humacyte, Inc. announced Robert J. Kossman, MD, FACP, FASN and Prabir Roy-Chaudhury, MD, PhD, FASN have joined the company as advisors. Posted 08-21-2026
- Byonyks on the Move: X-2 and X-3 APD Devices in Development Posted 07-16-2026
- Dr. Ben Reynolds and the Virtual Reality Kidney Dialysis Training Project Posted 06-17-2026